Rabdomiólisis como presentación inicial de COVID-19: caso Clínico / Rhabdomyolysis as the presentation form of COVID-19 infection: report of one case
Rev. méd. Chile
;
149(5): 796-802, mayo 2021. ilus, tab
Article
Dans Espagnol
| LILACS
| ID: biblio-1389522
ABSTRACT
COVID-19 infection causes a systemic inflammatory response, which mainly presents as a febrile syndrome with respiratory involvement. We report a 37-year-old male who consulted for myalgia, nausea and epigastric pain lasting three days. On admission, he had crepitations at the lung bases. The initial laboratory showed a creatine kinase of 62,768 U/L, a LDH of 1,110 IU/L, a creatinine a 2.1 mg/dL, an aspartate aminotransferase of 1,347 IU/L, a D-dimer of 1,140 ng/mL, a ferritin of 1,201 ng/mL and a lymphocyte count of 810 cells/mm3. The chest CT scan was compatible with multifocal pneumonia, suggesting a COVID-19 infection. COVID-19 PCR was positive. The patient was managed with hydration, sodium bicarbonate, ceftriaxone, and azithromycin, with a good clinical response.
Texte intégral:
Disponible
Indice:
LILAS (Amériques)
Sujet Principal:
Rhabdomyolyse
/
COVID-19
Limites du sujet:
Adulte
/
Humains
/
Mâle
langue:
Espagnol
Texte intégral:
Rev. méd. Chile
Thème du journal:
Médicament
Année:
2021
Type:
Article
Pays d'affiliation:
Chili
Institution/Pays d'affiliation:
Hospital Clínico Universidad de Chile/CL
Documents relatifs à ce sujet
MEDLINE
...
LILACS
LIS